Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)

Status:
Recruiting

Trial end date:
2020-12-01

Target enrollment:

Participant gender:

This is a multi-center, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis.

Phase 3

Vanda Pharmaceuticals